king-canute
14 Mar 2018
Daily Telegraph The Daily Telegraph gives good coverage of the results and says today "Fevertree sees off Schweppes to retain its fizz as UK's top mixer". Share price up this morning topped at £27.44. I bought several hundred more shares yesterday at 25.89 to add to my stockpile.We cannot realistically expect to see the same percentage increase in sales year on year.
Chicken Lips
13 Mar 2018
And the times a bit more upbeat Tim Warrillow, chief executive, insisted that there was “nothing in the results” to give investors any cause for caution or concern. He suggested that the fall was probably down to “a bit of profit-taking” after the shares briefly hit an all-time high of £28.83 yesterday.Andy Branchflower, finance director, said that because Fevertree was still a growth business now was not the time to be increasing the dividend policy, although he did confirm: “We won’t hold on to it for ever.”In the UK, its biggest market, sales grew by 96 per cent amid continuing demand for a premium gin and tonic, with the performance over the key Christmas trading period “particularly notable, with an impressive rate of sales growth across all channels, formats and flavours”.It said that it had ended the year as the best selling mixer brand in the UK off-trade by value, although Schweppes remains the number one by volume.In America, where it has just set up its own operation to oversee sales and distribution, sales grew by 36 per cent at constant currency, while in Europe sales were up 37 per cent on the same basis, helped by a growing taste among Italians and Germans for moscow mule cocktails made with vodka and Fevertree ginger beer.The group said that it continued to benefit from innovation, with sales of flavoured tonics jumping by 200 per cent, with particularly strong sales in the UK over Christmas of its limited-edition clementine tonic.The group reported revenues up 66 per cent to £170.2 million, just ahead of consensus forecasts of £169 million, while underlying earnings jumped by 64 per cent to £58.7 million on an adjusted basis. Pre-tax profits grew by 59 per cent to £56.4 million.[link]
Chicken Lips
13 Mar 2018
Results Made the Guardian News Well I think thats a first FECR in the Guardian News, so mainstream and investors radar.Fever-Tree tonic became the number one mixer brand in shops in Britain last year, and is also popular in North America, where people are consuming more long drinks. In Italy and Germany, the company’s non-alcoholic ginger beer brand, Moscow Mule, is selling well.Guardian Today: the headlines, the analysis, the debate - sent direct to you Read moreThe firm said annual revenues rose by 66% to £170m, propelling pretax profits up 64% to £56m in 2017.But the Aim-listed shares dropped 4% to £25.83, as investors were hoping for a better outlook.Warrilow said: “We have had an encouraging start to 2018 and remain confident that we are increasingly well positioned to deliver further growth across the business.”Neil Wilson, a senior market analyst at ETX Capital, said: “The market has become rather accustomed to Fever-Tree beating expectations and upgrading guidance, so when results are just moderately ahead, things look a little flat.”He added: “Fever-Tree will need to deliver on its promise to ‘reinvigorate the dark spirits category’ and do for this sector what it is done for gin over the last 10 years.”[link]
king-canute
13 Mar 2018
Re: Outlook statement ii stockbrokers at 14.08 hours quote me Bid:2,550p Offer:2,556p to deal, so some are now heartened by the Chairman's statement. I think the resistance level is now set at £25. I have enough shares to suit me but may add a few at these levels, will see how this afternoon closes in the final 30 minutes.
Cantseethewoodsforthetrees
13 Mar 2018
Re: Outlook statement That's the Chairman's statement. Not sure how much he's involved in the nitty-gritty.Just keep it bland, but positive. Say what you're told(perhaps).It seems the co. have plucked the 'low hanging fruit'(UK) which ahs given them the impetus to take on the RoW & US.So now comes the tricky bit!
Bribon
13 Mar 2018
Outlook statement For those who perhaps thought the outlook statement is disappointing, I paste belowboth last year”s and todays outlook. Spot the difference! Look at the results today and see what that statement led to in 2017. Here’s hoping for a similar meaning in 2018!We have had an encouraging start to 2017 and I look forward to working with my Board colleagues and the wider Fever-Tree team to continue to deliver growth.We have had an encouraging start to 2018 and I look forward to working with my Board colleagues and the wider Fever-Tree team to continue to deliver growth.
Chicken Lips
13 Mar 2018
Trading Just tried to get a price on FEVR has it been temporarily suspended with a near 200 point drop I was getting this 2,617.00p BID 2,370.00p Offer?
Dubliner2
13 Mar 2018
I wish all my holdings were as successful Who’s complaining ?· Revenue up 66% to £170.2m (2016: £102.2m)· Gross profit margin of 53.5% (2016: 55.2%)· Robust balance sheet with net cash at year end of £50.9m (2016: £26.9m)· Final dividend of 7.64 pence per share bringing total dividend to 10.65 pence per share (2016: 6.25 pence per share)What’s not to like? Surely volatility is due to short term speculators?I’m here for the long-term .
king-canute
13 Mar 2018
Re: Today's RNS Institutional shareholders don't invest for the short term, today's reversal is largely down to the PI speculators trying to make quick bucks, some may have caught a cold on the drop from Friday's high.Speculators don’t care about earnings or dividends. They bet on the price, and the price alone, none of them will become a Warren Buffett, not his style.I am an investor not a speculator, I have made investing mistakes but over 50 years of investing I have done very well on the whole.
peddlar
13 Mar 2018
Re: Beware on Tuesday Just as I suspected.The price is all over the place.You would think that the mms would have a clue as to whether the performance is good or ok.to me this lookalike a pretty good record,and they say that the outlook is still good.At best the price should steady.The CEO has always delivered thus far.
Chicken Lips
13 Mar 2018
Very quiet here today? Quiet here today?
Chicken Lips
13 Mar 2018
SP The reporting of results seems to now follow a pattern, not quite ramp and dump but significant build up to significant drop. So not too shabby update to performance has seen a 10% decrease over 2 days. I am not sure there is anything significant in terms of shorting but if I remember correctly the sell off continued for a period last year after results announce dragging PI's like me into action on a significant SIPP holding. Let's see Howe the SP pans out today, tomorrow.
Cantseethewoodsforthetrees
13 Mar 2018
Today's RNS Seem largely as expected-but market inevitably disappointed.Support at £25 should hold imho as long as institutions don't sell.
king-canute
12 Mar 2018
Re: Beware on Tuesday No doubt short term speculators last week, ducking out to realize their gains. I am amazed at the number of small value share deals probably making or losing a few pounds a deal for the holders.The results tomorrow may see the shares shoot up or down, ignoring that what counts is the medium and long term prospects for the company. Rolls and Warrillow the founders of the company have had a good track record going back to 2004, so watch out for enhancement of the product range.
peddlar
12 Mar 2018
Re: Beware on Tuesday The volatility has already started>>>>Where to at 16.30...
